Agrawal Neha, Gowrishankar Swarnalata
Department of Histopathology, Apollo Hospital, Jubilee Hills, Hyderabad, Telangana, India.
Indian J Nephrol. 2021 Jan-Feb;31(1):16-21. doi: 10.4103/ijn.IJN_380_19. Epub 2021 Jan 27.
IgA nephropathy (IgAN) is the most common form of glomerulonephritis across the world. Oxford classification defines criteria and effects of endocapillary hypercellularity on E score but the reproducibility of the same is debatable. Hence, there is a need for an objective marker that could establish a gold standard in assessing endocapillary hypercellularity.
Forty biopsies of proven IgAN were taken and grouped into two groups based on the presence or absence of endocapillary hypercellularity ( = 20 each). These biopsies were then stained by CD68 immune stain and the glomerular macrophages were quantified. Mean serum creatinine, presence of hypertension, degree of proteinuria and haematuria at the time of biopsy were also recorded and the correlation between these parameters and endocapillary hypercellularity was also studied.
Mean glomerular CD 68+ cell count was significantly higher in glomeruli showing endocapillary hypercellularity. Utilising the objective cutoff values of 0.6 CD68+ per glomerulus, more than 8 glomerular CD68+ cells in the entire biopsy and/or around 4 CD68+ cells in the most inflamed glomerulus, endocapillary hypercellularity can be predicted with a sensitivity of 70-80% and specificity of 70%. After regrouping the biopsies based on the cutoff values obtained from the receiver operating curve analysis the mean urine RBC count per high power field showed a significant correlation with endocapillary hypercellularity.
Glomerular CD68+ macrophage count seems to be a promising approach in assessing endocapillary hypercellularity. Further studies with emphasis on correlation with the clinical outcome are needed to validate its utility as an objective tool.
IgA肾病(IgAN)是全球最常见的肾小球肾炎形式。牛津分类法定义了毛细血管内细胞增多症对E评分的标准和影响,但其可重复性存在争议。因此,需要一种客观标志物来建立评估毛细血管内细胞增多症的金标准。
选取40例经证实的IgAN活检样本,根据有无毛细血管内细胞增多症分为两组(每组20例)。然后对这些活检样本进行CD68免疫染色,并对肾小球巨噬细胞进行定量分析。记录活检时的平均血清肌酐、高血压情况、蛋白尿程度和血尿情况,并研究这些参数与毛细血管内细胞增多症之间的相关性。
显示毛细血管内细胞增多症的肾小球中,平均肾小球CD68+细胞计数显著更高。利用每个肾小球0.6个CD68+细胞、整个活检样本中超过8个肾小球CD68+细胞和/或最炎症的肾小球中约4个CD68+细胞的客观临界值,可以预测毛细血管内细胞增多症,敏感性为70-80%,特异性为70%。根据从受试者工作曲线分析获得的临界值对活检样本重新分组后,每高倍视野的平均尿红细胞计数与毛细血管内细胞增多症显示出显著相关性。
肾小球CD68+巨噬细胞计数似乎是评估毛细血管内细胞增多症的一种有前景的方法。需要进一步研究以强调与临床结果的相关性,以验证其作为客观工具的实用性。